{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380004232001998216.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Masaaki Tamura"}],"foaf:familyName":[{"@value":"Tamura"}],"foaf:givenName":[{"@value":"Masaaki"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360004232001998208","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1016/j.bbrc.2017.11.102"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0006291X17322805?httpAccept=text/xml"},{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0006291X17322805?httpAccept=text/plain"},{"@type":"PMID","@value":"29155177"}],"notation":[{"@value":"Co-treatment with a C1B5 peptide of protein kinase Cγ and a low dose of gemcitabine strongly attenuated pancreatic cancer growth in mice through T cell activation"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.bbrc.2017.11.102_STr592w8otJUXvi87s51Lil738Y"},{"@type":"OPENAIRE","@value":"doi_dedup___::a0ceccf8262f6dcd083a056914fb5f3a_STr592w8otJUXvi87s51Lil738Y"}]}